A significant development in biotechnology and pharmaceutical manufacturing!
Zylidac Bio, part of the Zydus Lifesciences Group, has partnered with Prolific Machines to scale next-generation biologics manufacturing technology from early-stage development to Good Manufacturing Practice (GMP) production.
🔬 Key Highlights of the Partnership:
✅ Advanced Technology: Light-controlled protein expression technology designed to improve productivity, product quality and process control.
✅ Scalable Manufacturing: The collaboration will begin with technology transfer at a 50-litre scale, with plans to progress to 250 litres and subsequently to GMP manufacturing.
✅ End-to-End Capabilities: An integrated pathway covering cell line development, process scale-up, biologics manufacturing, fill-finish and packaging.
✅ Focus on Complex Biologics: The platform targets monoclonal antibodies, multispecific antibodies, fusion proteins, cytokines and other complex therapeutic proteins.
🌐 Industry Impact
This partnership highlights the growing role of advanced biotechnology, AI-driven process optimisation and integrated manufacturing infrastructure in accelerating the journey from laboratory research to clinical and commercial production.
As the global biopharmaceutical industry evolves, collaborations like this can help strengthen innovation, manufacturing efficiency and the development of next-generation therapeutics.
#PharmaceuticalIndustry #Biologics #Biotechnology #PharmaManufacturing #ZydusLifesciences #CDMO #ManufacturingInnovation #Healthcare #IndustrialDevelopment